Citation

Albert W. Wu, Dennis A. Revicki, Denise Jacobson, F. Malitz. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Research. 1997. 6: 481-93.

Citation

John S. Lambert, Raphael P. Viscidi, MaryClare Walker, Barbara Clayman, Marcy Winget, Marcelo Wolff, David H. Schwartz. Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine The NIAID sponsored AIDS Vaccine Evaluation Group. Clinical and Diagnostic Laboratory Immunology. 1997. 4: 302-8.

Citation

Fred M. Gordin, John P. Matts, Carol Miller, Lawrence S. Brown, Richard Hafner, Stanley L. John, Marina B. Klein, Anita Vaughn, C. Lynn Besch, George Perez, Susan Szabo, Wafaa M. El-Sadr. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. New England Journal of Medicine. 1997. 337: 315-20.

Citation

David Charles Perlman, Wafaa M. El-Sadr, Eileen T. Denning, John P. Matts, Edward Elliot Telzak, Nadim Salomon, Keith D. Chirgwin, Richard Hafner. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression.. Clinical Infectious Diseases. 1997. 25: 242-6.

Citation

L. M. Frenkel, D. E. Shapiro, D. H. Watts, B. Murante, S. Burchett, Y. J. Bryson, M. J. O'Sullivan, C. Mitchell. Analysis of the Maternal Components of the AIDS Clinical Trial Group 076 Zidovudine Regimen in the Prevention of Mother-to-Infant Transmission of Human Immunodeficiency Virus Type 1. Journal of Infectious Diseases. 1997. 175: 971-974.

Citation

William T. Shearer, Thomas C. Quinn, Philip LaRussa, Judy F. Lew, Lynne Mofenson, Susan Almay, Kenneth C. Rich, Edward Handelsman, Clemente Diaz, Marcello Pagano, Vincent Smeriglio, Leslie A. Kalish. Viral Load and Disease Progression In Infants Infected With Human Immunodeficiency Virus Type 1. New England Journal of Medicine. 1997. 336: 1337-1342.

Citation

J. M. Raboud, Julio S.G. Montaner, S. Rae, James O. Kahn, Scott M. Hammer, David Katzenstein, Andrew T. Pavia, Michael Hughes, Anne Cross, Mohan Beltangady, Jose M. Gatell Artigas, Lisa M. Dunkle, Laurie Smaldone. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. Antiviral Therapy. 1997. 2: 237-47.

Citation

William Lenderking, Marcia A. Testa, David Katzenstein, Scott M. Hammer. Measuring quality of life in early HIV disease: the modular approach. Quality of Life Research. 1997. 6: 515-30.

Citation

Janet L. Lathey, Ian Marschner, William Kabat, Stephen A. Spector. Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing. Journal of Clinical Microbiology. 1997. 35: 631-5.

Citation

K. Dahl, Elizabeth Keath, Victoria J. Fraser, William G. Powderly. Molecular epidemiology of mucosal candidiasis in HIV-positive women. AIDS Research and Human Retroviruses. 1997. 13: 485-91.